All lobbying filings

Missouri Hospital Association

Missouri Hospital Association filed a Q3 report for Missouri Hospital Association on October 19, 2026.

Lobbying for Missouri Hospital Association

As filed: MISSOURI HOSPITAL ASSOCIATION for MISSOURI HOSPITAL ASSOCIATION.

All filings by Missouri Hospital Association · Everything Missouri Hospital Association has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Expenses

$97,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Missouri

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

- Corresponded with a member of the Missouri congressional delegation health staffer to distribute the CY2026 vs CY2027 proposed Medicare OPPS update. - Corresponded with members of the Missouri congressional delegation health staffers regarding CMS 340B actions. - Corresponded with members of the Missouri congressional delegation health staffers regarding access to CLFS for required certification deadline of July 31. - Corresponded with members of the Missouri congressional delegation health staffers to convene in-person meetings with Missouri congressional members. - Corresponded with a member of the Missouri congressional delegation health staffer to discuss Medicare Physician Fee Schedule update for CY 2027. - Corresponded with a member of the Missouri congressional delegation health staffer to distribute a copy of the Missouri Hospital Association comment letter to CMS regarding CY 2027 OPPS. - Corresponded with a member of the Missouri congressional delegation to thank congressman for introduction of H.R. 10394. - Corresponded with a member of the Missouri congressional delegation health staffer to discuss CMS proposed 340B changes. - Corresponded with a member of the Missouri congressional delegation health staffer regarding a comment letter to CMS on EMS/GEMT. - Corresponded with a member of the Missouri congressional delegation health staffer regarding the agreement between HRSA and pharmaceutical manufactures called Pharmaceutical Pricing Agreement. - Corresponded with a member of Health and Human Service to convene an in-person meeting to tour a local Missouri hospital. - Corresponded with a member of the Missouri congressional delegation health staffer to discuss a sign-on letter against Eli Lillys 340B action. - Corresponded with a member of the Missouri congressional delegation health staffer to discuss W&M markup. - Corresponded with a member of the Missouri congressional delegation health staffer to discuss H.R. 9645. - Corresponded with members of the Missouri congressional delegation health staffers to discuss HRSA 340B RFI comment letter. - Convened a virtual meeting to update Missouri congressional delegation health staffers on current hospital and health care issues. - Convened in-person meetings in Washington, DC with members of the Missouri congressional delegation and/or health staffers to discuss current hospital and health care issues.

Bills named in this filing 2

H.R. 10394
Protecting Approved Care Act
H.R. 9645
Health Care Price Certainty for All Americans Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.